|Bid||210.98 x 900|
|Ask||216.22 x 900|
|Day's Range||207.88 - 216.56|
|52 Week Range||183.46 - 336.99|
|Beta (5Y Monthly)||1.44|
|PE Ratio (TTM)||15.82|
|Earnings Date||Feb. 23, 2022 - Feb. 28, 2022|
|Forward Dividend & Yield||5.68 (2.58%)|
|Ex-Dividend Date||Sep. 20, 2021|
|1y Target Est||348.00|
Is Medifast (MED) a great pick from the value investor's perspective right now? Read on to know more.
Medifast CEO Dan Chard discusses how his company has outpaced 2021 and Q3 estimates, as it has modified its healthy living service model to focus more on direct-to-consumer.
At this time, I would like to turn the conference over to Reed Anderson with ICR. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.